FDA Approves Imaging Agent Designed to Target Tumors in Lung Cancer.
- Published in:
- Oncology (08909091), 2023, v. 37, n. 2, p. 53
- By:
- Publication type:
- Article
Works matching IS 08909091 AND DT 2023 AND VI 37 AND IP 2
Results: 5
1
2
Society for Urologic Oncology (SUO) 23rd Annual Meeting.
- Published in:
- Oncology (08909091), 2023, v. 37, n. 2, p. 78
- Publication type:
- Article
3
COVID-19 Vaccination in Patients With Cancer and Recipients of Cellular Therapy.
- Published in:
- Oncology (08909091), 2023, v. 37, n. 2, p. 69, doi. 10.46883/2023.25920985
- By:
- Publication type:
- Article
4
Cutaneous T-Cell Lymphoma: Current and Emerging Therapies.
- Published in:
- Oncology (08909091), 2023, v. 37, n. 2, p. 55, doi. 10.46883/2023.25920984
- By:
- Publication type:
- Article
5
American Society of Hematology: 64th Annual Meeting Review.
- Published in:
- Oncology (08909091), 2023, v. 37, n. 2, p. 52
- By:
- Publication type:
- Article